Back to search
FDAFDA · Food and drugs·Recall number Z-1742-2024

RayStation 8.0.0.61, 8.0.1.10. Radiation Therapy Treatment Planning System.

Published May 8, 2024 · Recall initiated: March 28, 2024

Summary

FDA records medical device Class II recall Z-1742-2024, published May 8, 2024 and initiated March 28, 2024. Recalling firm: RAYSEARCH LABORATORIES AB; Status: Ongoing; Reported quantity: 9 units; Lot: UDI: 0735000201011220180608 and 0735000201013620180928; GTIN: 07350002010112 and 07350002010136; Serial Numbers: 8.0.0.61 and 8.0.1.10 Software Revisions: RayStation/RayPlan 8A and 8A Service Pack 1; Expiration Date: 2023-10-04. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Potential for reported SSD to be too high.

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
RAYSEARCH LABORATORIES AB
Distributor
Worldwide distribution - US Nationwide and the countries of Algeria, Australia, Austria, Bahrain, Belgium, Canada, China, Colombia, Cyprus, Czech Republic, Denmark, Egypt, Estonia, France, Germany, Hungary, India, Indonesia, Iran, Israel, Italy, Japan, Korea, Malaysia, Morocco, Netherlands, New Zealand, Norway, Poland, Qatar, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, UAE, UK.
Lot
UDI: 0735000201011220180608 and 0735000201013620180928; GTIN: 07350002010112 and 07350002010136; Serial Numbers: 8.0.0.61 and 8.0.1.10 Software Revisions: RayStation/RayPlan 8A and 8A Service Pack 1; Expiration Date: 2023-10-04.
Risk classification
Class II
Area (FDA)
device
Country
Sweden

Related recalls

Questions about this recall

Was RayStation 8.0.0.61, 8.0.1.10. Radiation Therapy Treatment Planning System. recalled?

Yes. FDA published recall Z-1742-2024 on May 8, 2024. Reported hazard: Potential for reported SSD to be too high.

What should I do if I have this product?

Voluntary: Firm initiated